08:45 AM EDT, 08/12/2024 (MT Newswires) -- Health care stocks were flat to higher pre-bell Monday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was up 0.3% recently.

Ascendis Pharma ( ASND ) shares were over 10% higher after saying the US Food and Drug Administration has approved Yorvipath, the company's treatment for hypoparathyroidism, a rare endocrine disease, in adults.